StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage Zero is down 99.95% in one year! FACTS

<< Previous

Bullboard Posts

Next >>

Comment by Thehuntsmanon Oct 12, 2022 4:31pm

107 Views

Post# 35020636

RE:Stage Zero is down 99.95% in one year! FACTS

Am I the only one quaking in his boots right now? Here's some tinfoil, make a hat.

nomorebase wrote: Anyone who defends this garbage company is an insider. FACT.
All IP addresses are being tracked, for over 3 years.

This paid pumping scheme will be broken wide open very soon.

Mark my words.